Spinal Disorders

Spinal Disorders News

  • 'Fears Allayed' by Latest Infliximab Biosimilar Evidence The biosimilar is noninferior to the originator infliximab in patients with stable Crohn's disease, ulcerative colitis, and other inflammatory conditions, two studies demonstrate.
  • Even Short-term Oral Steroids Carry Serious Risk A large, population-based study found a significantly higher rate of acute adverse events such as sepsis, venous thromboembolism, and fracture, even after a low-dose, short-term steroid treatment.
 

Spinal Disorders Perspective

 

Journals